Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17649
Country/Region: Uganda
Year: 2018
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $9,863,633 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,625,742
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $429,656
Care: Pediatric Care and Support (PDCS) $595,065
Laboratory Infrastructure (HLAB) $150,000
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,323,050
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $759,356
Sexual Prevention: Other Sexual Prevention (HVOP) $480,325
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $612,799
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $3,686,533
Treatment: Pediatric Treatment (PDTX) $201,107
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 90
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 67
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 51
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 6
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 240
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 209
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 86
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 14
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 2,096
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 1,912
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 214
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 71
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 1,024
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 581
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 509
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 245
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 378
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 42
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 260
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 378
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 42
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 260
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 378
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 42
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 260
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 126
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 14
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 86
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 5
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 267
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 22
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 164
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 14
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 1,000
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 6,867
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 3,331
GEND_GBV Number of people receiving post-GBV care 2019 10,198
HTS_SELF 15-19, Female, Directly-Assisted 2019 275
HTS_SELF 15-19, Female, Directly-Assisted 2019 51
HTS_SELF 15-19, Female, Unassisted 2019 719
HTS_SELF 15-19, Female, Unassisted 2019 139
HTS_SELF 20-24, Female, Directly-Assisted 2019 724
HTS_SELF 20-24, Female, Directly-Assisted 2019 142
HTS_SELF 20-24, Female, Unassisted 2019 2,155
HTS_SELF 20-24, Female, Unassisted 2019 419
HTS_SELF 20-24, Male, Directly-Assisted 2019 35
HTS_SELF 20-24, Male, Directly-Assisted 2019 7
HTS_SELF 20-24, Male, Unassisted 2019 35
HTS_SELF 20-24, Male, Unassisted 2019 7
HTS_SELF 25-29, Female, Directly-Assisted 2019 431
HTS_SELF 25-29, Female, Directly-Assisted 2019 85
HTS_SELF 25-29, Female, Unassisted 2019 1,435
HTS_SELF 25-29, Female, Unassisted 2019 279
HTS_SELF 25-29, Male, Directly-Assisted 2019 35
HTS_SELF 25-29, Male, Directly-Assisted 2019 7
HTS_SELF 25-29, Male, Unassisted 2019 35
HTS_SELF 25-29, Male, Unassisted 2019 7
HTS_SELF 30-34, Female, Directly-Assisted 2019 245
HTS_SELF 30-34, Female, Directly-Assisted 2019 48
HTS_SELF 30-34, Female, Unassisted 2019 575
HTS_SELF 30-34, Female, Unassisted 2019 111
HTS_SELF 35-39, Female, Directly-Assisted 2019 100
HTS_SELF 35-39, Female, Directly-Assisted 2019 19
HTS_SELF 35-39, Female, Unassisted 2019 286
HTS_SELF 35-39, Female, Unassisted 2019 56
HTS_SELF 40-49, Female, Directly-Assisted 2019 29
HTS_SELF 40-49, Female, Directly-Assisted 2019 6
HTS_SELF 40-49, Female, Unassisted 2019 71
HTS_SELF 40-49, Female, Unassisted 2019 13
HTS_SELF FSW, Directly-Assisted 2019 357
HTS_SELF FSW, Directly-Assisted 2019 71
HTS_SELF FSW, Unassisted 2019 1,078
HTS_SELF FSW, Unassisted 2019 210
HTS_SELF MSM, Directly-Assisted 2019 71
HTS_SELF MSM, Directly-Assisted 2019 13
HTS_SELF MSM, Unassisted 2019 71
HTS_SELF MSM, Unassisted 2019 13
HTS_SELF Unassisted - Sex Partner 2019 7,181
HTS_SELF Unassisted - Sex Partner 2019 1,400
HTS_TST <5, Unknown Sex, Negative 2019 651
HTS_TST <5, Unknown Sex, Negative 2019 1,524
HTS_TST 15-19, Female, Negative 2019 79
HTS_TST 15-19, Female, Negative 2019 141
HTS_TST 15-19, Male, Negative 2019 25
HTS_TST 15-19, Male, Negative 2019 47
HTS_TST 20-24, Female, Negative 2019 155
HTS_TST 20-24, Female, Negative 2019 257
HTS_TST 20-24, Male, Negative 2019 66
HTS_TST 20-24, Male, Negative 2019 117
HTS_TST 25-29, Female, Negative 2019 320
HTS_TST 25-29, Female, Negative 2019 277
HTS_TST 25-29, Female, Negative 2019 549
HTS_TST 25-29, Female, Negative 2019 2,891
HTS_TST 25-29, Female, Negative 2019 1,195
HTS_TST 25-29, Female, Negative 2019 13,465
HTS_TST 25-29, Female, Negative 2019 2,790
HTS_TST 25-29, Female, Negative 2019 192
HTS_TST 25-29, Female, Negative 2019 657
HTS_TST 25-29, Female, Negative 2019 47
HTS_TST 25-29, Female, Negative 2019 4,837
HTS_TST 25-29, Female, Negative 2019 17,038
HTS_TST 25-29, Female, Negative 2019 329
HTS_TST 25-29, Female, Negative 2019 102
HTS_TST 25-29, Male, Negative 2019 266
HTS_TST 25-29, Male, Negative 2019 182
HTS_TST 25-29, Male, Negative 2019 452
HTS_TST 25-29, Male, Negative 2019 2,972
HTS_TST 25-29, Male, Negative 2019 790
HTS_TST 25-29, Male, Negative 2019 2,287
HTS_TST 25-29, Male, Negative 2019 124
HTS_TST 25-29, Male, Negative 2019 539
HTS_TST 25-29, Male, Negative 2019 28
HTS_TST 25-29, Male, Negative 2019 4,986
HTS_TST 25-29, Male, Negative 2019 1,946
HTS_TST 25-29, Male, Negative 2019 214
HTS_TST 25-29, Male, Negative 2019 63
HTS_TST 25-29, Male, Negative 2019 14,895
HTS_TST 30-34, Female, Negative 2019 76
HTS_TST 30-34, Female, Negative 2019 118
HTS_TST 30-34, Female, Negative 2019 133
HTS_TST 30-34, Female, Negative 2019 1,036
HTS_TST 30-34, Female, Negative 2019 518
HTS_TST 30-34, Female, Negative 2019 5,828
HTS_TST 30-34, Female, Negative 2019 665
HTS_TST 30-34, Female, Negative 2019 79
HTS_TST 30-34, Female, Negative 2019 156
HTS_TST 30-34, Female, Negative 2019 59
HTS_TST 30-34, Female, Negative 2019 1,729
HTS_TST 30-34, Female, Negative 2019 7,372
HTS_TST 30-34, Female, Negative 2019 141
HTS_TST 30-34, Female, Negative 2019 123
HTS_TST 30-34, Male, Negative 2019 207
HTS_TST 30-34, Male, Negative 2019 121
HTS_TST 30-34, Male, Negative 2019 347
HTS_TST 30-34, Male, Negative 2019 1,906
HTS_TST 30-34, Male, Negative 2019 526
HTS_TST 30-34, Male, Negative 2019 1,766
HTS_TST 30-34, Male, Negative 2019 80
HTS_TST 30-34, Male, Negative 2019 418
HTS_TST 30-34, Male, Negative 2019 38
HTS_TST 30-34, Male, Negative 2019 3,192
HTS_TST 30-34, Male, Negative 2019 261
HTS_TST 30-34, Male, Negative 2019 146
HTS_TST 30-34, Male, Negative 2019 82
HTS_TST 30-34, Male, Negative 2019 1,986
HTS_TST 35-39, Female, Negative 2019 146
HTS_TST 35-39, Female, Negative 2019 123
HTS_TST 35-39, Female, Negative 2019 248
HTS_TST 35-39, Female, Negative 2019 1,142
HTS_TST 35-39, Female, Negative 2019 539
HTS_TST 35-39, Female, Negative 2019 6,049
HTS_TST 35-39, Female, Negative 2019 1,252
HTS_TST 35-39, Female, Negative 2019 82
HTS_TST 35-39, Female, Negative 2019 296
HTS_TST 35-39, Female, Negative 2019 73
HTS_TST 35-39, Female, Negative 2019 1,911
HTS_TST 35-39, Female, Negative 2019 7,656
HTS_TST 35-39, Female, Negative 2019 149
HTS_TST 35-39, Female, Negative 2019 156
HTS_TST 35-39, Male, Negative 2019 245
HTS_TST 35-39, Male, Negative 2019 165
HTS_TST 35-39, Male, Negative 2019 413
HTS_TST 35-39, Male, Negative 2019 2,156
HTS_TST 35-39, Male, Negative 2019 706
HTS_TST 35-39, Male, Negative 2019 2,098
HTS_TST 35-39, Male, Negative 2019 110
HTS_TST 35-39, Male, Negative 2019 495
HTS_TST 35-39, Male, Negative 2019 117
HTS_TST 35-39, Male, Negative 2019 3,617
HTS_TST 35-39, Male, Negative 2019 261
HTS_TST 35-39, Male, Negative 2019 194
HTS_TST 35-39, Male, Negative 2019 246
HTS_TST 35-39, Male, Negative 2019 1,986
HTS_TST 40-49, Female, Negative 2019 110
HTS_TST 40-49, Female, Negative 2019 83
HTS_TST 40-49, Female, Negative 2019 195
HTS_TST 40-49, Female, Negative 2019 924
HTS_TST 40-49, Female, Negative 2019 364
HTS_TST 40-49, Female, Negative 2019 4,077
HTS_TST 40-49, Female, Negative 2019 1,151
HTS_TST 40-49, Female, Negative 2019 52
HTS_TST 40-49, Female, Negative 2019 272
HTS_TST 40-49, Female, Negative 2019 47
HTS_TST 40-49, Female, Negative 2019 1,554
HTS_TST 40-49, Female, Negative 2019 5,158
HTS_TST 40-49, Female, Negative 2019 103
HTS_TST 40-49, Female, Negative 2019 102
HTS_TST 40-49, Male, Negative 2019 310
HTS_TST 40-49, Male, Negative 2019 152
HTS_TST 40-49, Male, Negative 2019 522
HTS_TST 40-49, Male, Negative 2019 1,751
HTS_TST 40-49, Male, Negative 2019 658
HTS_TST 40-49, Male, Negative 2019 2,649
HTS_TST 40-49, Male, Negative 2019 101
HTS_TST 40-49, Male, Negative 2019 623
HTS_TST 40-49, Male, Negative 2019 47
HTS_TST 40-49, Male, Negative 2019 261
HTS_TST 40-49, Male, Negative 2019 2,925
HTS_TST 40-49, Male, Negative 2019 183
HTS_TST 40-49, Male, Negative 2019 102
HTS_TST 40-49, Male, Negative 2019 1,986
HTS_TST 50+, Female, Negative 2019 6
HTS_TST 50+, Male, Negative 2019 48
HTS_TST 50+, Male, Negative 2019 88
HTS_TST By Key Population: FSW, Negative 2019 1,427
HTS_TST By Key Population: FSW, Negative 2019 1,409
HTS_TST By Key Population: MSM, Negative 2019 190
HTS_TST By Key Population: MSM, Negative 2019 105
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 3,298
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 4,239
HTS_TST By Key Population: TG, Negative 2019 70
HTS_TST By Key Population: TG, Negative 2019 37
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 259,965
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 113,576
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 1,482
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 1,618
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 345
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 128
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 64
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 85
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 237
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 266
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 539
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 270
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 361
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 1,000
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 6
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 1,132
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 11,647
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 14,732
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 20,229
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 25,595
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 441
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,040
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 482
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 1,135
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 103
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 242
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 62
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 108
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 29
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 56
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 101
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 183
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 115
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 199
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 87
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 157
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 5,961
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 332
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 6,522
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 364
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 1,387
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 78
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 517
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 118
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 169
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 38
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 962
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 220
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 430
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 98
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 9
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 325
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 73
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 8,036
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 3,429
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 3,745
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 8,776
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 792
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 1,852
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,183
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,976
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 590
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 987
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,776
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 2,971
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,904
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 3,190
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 18
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 39
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 820
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,369
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 12,447
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 5,309
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 47
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 102
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 42
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 17
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 22
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 9
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 68
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 144
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 104
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 222
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 117
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 246
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 47
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 102
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 28
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 63
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 68
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 144
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 324
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 2,484
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 1,623
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 12,417
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 1,623
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 12,417
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 194
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 1,490
HTS_TST_POS <5, Unknown Sex, Positive 2019 23
HTS_TST_POS <5, Unknown Sex, Positive 2019 68
HTS_TST_POS 15-19, Female, Positive 2019 4
HTS_TST_POS 15-19, Female, Positive 2019 13
HTS_TST_POS 15-19, Male, Positive 2019 4
HTS_TST_POS 20-24, Female, Positive 2019 8
HTS_TST_POS 20-24, Female, Positive 2019 23
HTS_TST_POS 20-24, Male, Positive 2019 2
HTS_TST_POS 20-24, Male, Positive 2019 11
HTS_TST_POS 25-29, Female, Positive 2019 52
HTS_TST_POS 25-29, Female, Positive 2019 15
HTS_TST_POS 25-29, Female, Positive 2019 102
HTS_TST_POS 25-29, Female, Positive 2019 86
HTS_TST_POS 25-29, Female, Positive 2019 64
HTS_TST_POS 25-29, Female, Positive 2019 203
HTS_TST_POS 25-29, Female, Positive 2019 116
HTS_TST_POS 25-29, Female, Positive 2019 12
HTS_TST_POS 25-29, Female, Positive 2019 116
HTS_TST_POS 25-29, Female, Positive 2019 28
HTS_TST_POS 25-29, Female, Positive 2019 152
HTS_TST_POS 25-29, Female, Positive 2019 243
HTS_TST_POS 25-29, Female, Positive 2019 26
HTS_TST_POS 25-29, Female, Positive 2019 44
HTS_TST_POS 25-29, Male, Positive 2019 46
HTS_TST_POS 25-29, Male, Positive 2019 9
HTS_TST_POS 25-29, Male, Positive 2019 82
HTS_TST_POS 25-29, Male, Positive 2019 88
HTS_TST_POS 25-29, Male, Positive 2019 43
HTS_TST_POS 25-29, Male, Positive 2019 95
HTS_TST_POS 25-29, Male, Positive 2019 6
HTS_TST_POS 25-29, Male, Positive 2019 95
HTS_TST_POS 25-29, Male, Positive 2019 16
HTS_TST_POS 25-29, Male, Positive 2019 158
HTS_TST_POS 25-29, Male, Positive 2019 5
HTS_TST_POS 25-29, Male, Positive 2019 21
HTS_TST_POS 25-29, Male, Positive 2019 25
HTS_TST_POS 25-29, Male, Positive 2019 40
HTS_TST_POS 30-34, Female, Positive 2019 11
HTS_TST_POS 30-34, Female, Positive 2019 7
HTS_TST_POS 30-34, Female, Positive 2019 25
HTS_TST_POS 30-34, Female, Positive 2019 29
HTS_TST_POS 30-34, Female, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 164
HTS_TST_POS 30-34, Female, Positive 2019 29
HTS_TST_POS 30-34, Female, Positive 2019 4
HTS_TST_POS 30-34, Female, Positive 2019 29
HTS_TST_POS 30-34, Female, Positive 2019 37
HTS_TST_POS 30-34, Female, Positive 2019 57
HTS_TST_POS 30-34, Female, Positive 2019 185
HTS_TST_POS 30-34, Female, Positive 2019 13
HTS_TST_POS 30-34, Female, Positive 2019 49
HTS_TST_POS 30-34, Male, Positive 2019 33
HTS_TST_POS 30-34, Male, Positive 2019 7
HTS_TST_POS 30-34, Male, Positive 2019 64
HTS_TST_POS 30-34, Male, Positive 2019 53
HTS_TST_POS 30-34, Male, Positive 2019 28
HTS_TST_POS 30-34, Male, Positive 2019 73
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 30-34, Male, Positive 2019 73
HTS_TST_POS 30-34, Male, Positive 2019 24
HTS_TST_POS 30-34, Male, Positive 2019 104
HTS_TST_POS 30-34, Male, Positive 2019 13
HTS_TST_POS 30-34, Male, Positive 2019 33
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 24
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Female, Positive 2019 45
HTS_TST_POS 35-39, Female, Positive 2019 32
HTS_TST_POS 35-39, Female, Positive 2019 28
HTS_TST_POS 35-39, Female, Positive 2019 67
HTS_TST_POS 35-39, Female, Positive 2019 52
HTS_TST_POS 35-39, Female, Positive 2019 4
HTS_TST_POS 35-39, Female, Positive 2019 52
HTS_TST_POS 35-39, Female, Positive 2019 44
HTS_TST_POS 35-39, Female, Positive 2019 62
HTS_TST_POS 35-39, Female, Positive 2019 83
HTS_TST_POS 35-39, Female, Positive 2019 13
HTS_TST_POS 35-39, Female, Positive 2019 63
HTS_TST_POS 35-39, Male, Positive 2019 40
HTS_TST_POS 35-39, Male, Positive 2019 8
HTS_TST_POS 35-39, Male, Positive 2019 76
HTS_TST_POS 35-39, Male, Positive 2019 65
HTS_TST_POS 35-39, Male, Positive 2019 39
HTS_TST_POS 35-39, Male, Positive 2019 88
HTS_TST_POS 35-39, Male, Positive 2019 6
HTS_TST_POS 35-39, Male, Positive 2019 88
HTS_TST_POS 35-39, Male, Positive 2019 71
HTS_TST_POS 35-39, Male, Positive 2019 115
HTS_TST_POS 35-39, Male, Positive 2019 17
HTS_TST_POS 35-39, Male, Positive 2019 99
HTS_TST_POS 35-39, Male, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 37
HTS_TST_POS 40-49, Female, Positive 2019 26
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Female, Positive 2019 18
HTS_TST_POS 40-49, Female, Positive 2019 48
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 48
HTS_TST_POS 40-49, Female, Positive 2019 28
HTS_TST_POS 40-49, Female, Positive 2019 52
HTS_TST_POS 40-49, Female, Positive 2019 31
HTS_TST_POS 40-49, Female, Positive 2019 9
HTS_TST_POS 40-49, Female, Positive 2019 44
HTS_TST_POS 40-49, Male, Positive 2019 52
HTS_TST_POS 40-49, Male, Positive 2019 7
HTS_TST_POS 40-49, Male, Positive 2019 95
HTS_TST_POS 40-49, Male, Positive 2019 51
HTS_TST_POS 40-49, Male, Positive 2019 35
HTS_TST_POS 40-49, Male, Positive 2019 111
HTS_TST_POS 40-49, Male, Positive 2019 6
HTS_TST_POS 40-49, Male, Positive 2019 111
HTS_TST_POS 40-49, Male, Positive 2019 28
HTS_TST_POS 40-49, Male, Positive 2019 94
HTS_TST_POS 40-49, Male, Positive 2019 16
HTS_TST_POS 40-49, Male, Positive 2019 44
HTS_TST_POS 40-49, Male, Positive 2019 6
HTS_TST_POS 50+, Male, Positive 2019 2
HTS_TST_POS 50+, Male, Positive 2019 8
HTS_TST_POS By Key Population: FSW, Positive 2019 651
HTS_TST_POS By Key Population: FSW, Positive 2019 678
HTS_TST_POS By Key Population: MSM, Positive 2019 83
HTS_TST_POS By Key Population: MSM, Positive 2019 48
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 633
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 853
HTS_TST_POS By Key Population: TG, Positive 2019 12
HTS_TST_POS By Key Population: TG, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 78
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 85
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 41
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 48
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 41
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 182
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 211
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 318
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 365
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 59
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 38
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 196
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 203
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 50
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 171
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 171
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 64
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 95
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 104
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 257
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 104
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 42
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 56
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 63
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 85
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 71
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 99
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 42
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 56
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 4
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 2,935
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 401
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 3,910
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 33
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 7,279
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,705
PMTCT_ART Already on ART at beginning of current pregnancy 2019 720
PMTCT_ART New on ART 2019 1,530
PMTCT_ART New on ART 2019 407
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 4,235
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 1,127
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 118,638
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 25,849
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 3,590
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 930
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 645
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 197
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 4,235
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 1,127
PMTCT_EID Sum of Infant Age disaggregates 2019 4,235
PMTCT_EID Sum of Infant Age disaggregates 2019 1,127
PMTCT_STAT 25-29, Female 2019 26,103
PMTCT_STAT 25-29, Female 2019 5,686
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 1,243
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 335
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 24,497
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 5,259
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 363
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 92
PMTCT_STAT 30-34, Female 2019 20,169
PMTCT_STAT 30-34, Female 2019 4,394
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 963
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 257
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 18,925
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 4,065
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 281
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 72
PMTCT_STAT 35-39, Female 2019 8,305
PMTCT_STAT 35-39, Female 2019 1,809
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 399
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 106
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 7,786
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 1,676
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 120
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 27
PMTCT_STAT 40-49, Female 2019 2,373
PMTCT_STAT 40-49, Female 2019 516
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 120
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 29
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 2,215
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 485
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 38
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 2
PMTCT_STAT By Age (Numerator): : 15-19 2019 4,909
PMTCT_STAT By Age (Numerator): 15-19 2019 22,544
PMTCT_STAT By Age (Numerator): 20-24 2019 39,144
PMTCT_STAT By Age (Numerator): 20-24 2019 8,535
PMTCT_STAT By known positives: 15-19 2019 1
PMTCT_STAT By known positives: 20-24 2019 16
PMTCT_STAT By new negatives: 15-19 2019 4,827
PMTCT_STAT By new negatives: 20-24 2019 8,379
PMTCT_STAT By new positives: 15-19 2019 81
PMTCT_STAT By new positives: 20-24 2019 140
PMTCT_STAT By Number of known positives: 15-19 2019 16
PMTCT_STAT By Number of known positives: 20-24 2019 89
PMTCT_STAT By Number of new negative: 15-19 2019 22,216
PMTCT_STAT By Number of new negative: 20-24 2019 38,512
PMTCT_STAT By Number of new positives: 15-19 2019 312
PMTCT_STAT By Number of new positives: 20-24 2019 543
PMTCT_STAT Number of new ANC and L&D clients 2019 118,638
PMTCT_STAT Number of new ANC and L&D clients 2019 25,849
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 118,638
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 25,849
PMTCT_STAT_den 25-29, Female 2019 26,103
PMTCT_STAT_den 25-29, Female 2019 5,686
PMTCT_STAT_den 30-34, Female 2019 20,169
PMTCT_STAT_den 30-34, Female 2019 4,394
PMTCT_STAT_den 35-39, Female 2019 8,305
PMTCT_STAT_den 35-39, Female 2019 1,809
PMTCT_STAT_den 40-49, Female 2019 2,373
PMTCT_STAT_den 40-49, Female 2019 516
PMTCT_STAT_den By Age (Denominator): <15-19 2019 22,544
PMTCT_STAT_den By Age (Denominator): 15-19 2019 4,909
PMTCT_STAT_den By Age (Denominator): 20-24 2019 39,144
PMTCT_STAT_den By Age (Denominator): 20-24 2019 8,535
PP_PREV 25-29, Female 2019 2,368
PP_PREV 25-29, Male 2019 4,216
PP_PREV 30-34, Female 2019 2,360
PP_PREV 30-34, Male 2019 4,241
PP_PREV 35-39, Female 2019 1,501
PP_PREV 35-39, Male 2019 2,684
PP_PREV 40-49, Female 2019 2,123
PP_PREV 40-49, Male 2019 3,781
PP_PREV Age/sex: 10-14 Female 2019 4,006
PP_PREV Age/sex: 15-19 Female 2019 11,991
PP_PREV Age/sex: 15-19 Male 2019 1,023
PP_PREV Age/sex: 20-24 Female 2019 7,912
PP_PREV Age/sex: 20-24 Male 2019 2,068
PP_PREV Age/sex: 50+ Female 2019 452
PP_PREV Age/sex: 50+ Male 2019 825
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 51,551
PP_PREV Sum of Age/Sex disaggregates 2019 28,277
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 75
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 26
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 440
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 163
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 69
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 23
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 745
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 284
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,329
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 496
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 10,955
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 1,729
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 1,260
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 200
TB_PREV By Age/Sex (Numerator): <15, Female 2019 755
TB_PREV By Age/Sex (Numerator): <15, Female 2019 119
TB_PREV By Age/Sex (Numerator): <15, Male 2019 504
TB_PREV By Age/Sex (Numerator): <15, Male 2019 80
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 7,688
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 1,208
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 3,651
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 579
TB_PREV IPT, Life-long ART, Already, Positive 2019 329
TB_PREV IPT, Life-long ART, Already, Positive 2019 51
TB_PREV IPT, Life-long ART, New, Positive 2019 54
TB_PREV IPT, Life-long ART, New, Positive 2019 6
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 12,598
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 1,986
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 14,821
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 2,336
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 12,892
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 2,032
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 1,483
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 234
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 890
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 139
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 595
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 93
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 9,039
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 1,427
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 4,297
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 677
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 384
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 63
TB_PREV_den IPT, Life-long ART, New, Positive 2019 62
TB_PREV_den IPT, Life-long ART, New, Positive 2019 7
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 192
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 52
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,127
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 314
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 208
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 56
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,282
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 627
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 3,809
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,049
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 3,809
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,049
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 192
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 52
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,127
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 314
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 208
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 56
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,282
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 627
TX_CURR 25-29, Female, Positive 2019 6,940
TX_CURR 25-29, Female, Positive 2019 1,128
TX_CURR 25-29, Male, Positive 2019 1,225
TX_CURR 25-29, Male, Positive 2019 198
TX_CURR 30-34, Female, Positive 2019 9,920
TX_CURR 30-34, Female, Positive 2019 1,613
TX_CURR 30-34, Male, Positive 2019 2,912
TX_CURR 30-34, Male, Positive 2019 472
TX_CURR 35-39, Female, Positive 2019 8,109
TX_CURR 35-39, Female, Positive 2019 1,317
TX_CURR 35-39, Male, Positive 2019 3,803
TX_CURR 35-39, Male, Positive 2019 616
TX_CURR 40-49, Female, Positive 2019 11,940
TX_CURR 40-49, Female, Positive 2019 1,937
TX_CURR 40-49, Male, Positive 2019 9,884
TX_CURR 40-49, Male, Positive 2019 1,606
TX_CURR Age/Sex: <1 2019 468
TX_CURR Age/Sex: <1 2019 47
TX_CURR Age/Sex: <1-9 2019 2,869
TX_CURR Age/Sex: 1-9 2019 292
TX_CURR Age/Sex: 10-14 Female 2019 2,337
TX_CURR Age/Sex: 10-14 Female 2019 236
TX_CURR Age/Sex: 10-14 Male 2019 1,000
TX_CURR Age/Sex: 10-14 Male 2019 103
TX_CURR Age/Sex: 15-19 Female 2019 267
TX_CURR Age/Sex: 15-19 Female 2019 1,642
TX_CURR Age/Sex: 15-19 Male 2019 45
TX_CURR Age/Sex: 15-19 Male 2019 278
TX_CURR Age/Sex: 20-24 Female 2019 4,864
TX_CURR Age/Sex: 20-24 Female 2019 792
TX_CURR Age/Sex: 20-24 Male 2019 423
TX_CURR Age/Sex: 20-24 Male 2019 69
TX_CURR Age/Sex: 50+ Female 2019 8,737
TX_CURR Age/Sex: 50+ Female 2019 1,421
TX_CURR Age/Sex: 50+ Male 2019 5,824
TX_CURR Age/Sex: 50+ Male 2019 946
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 13,105
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 83,175
TX_CURR Sum of age/sex disaggregates 2019 1,920
TX_CURR Sum of Age/Sex disaggregations 2019 312
TX_NEW 25-29, Female, Positive 2019 1,089
TX_NEW 25-29, Female, Positive 2019 162
TX_NEW 25-29, Male, Positive 2019 716
TX_NEW 25-29, Male, Positive 2019 101
TX_NEW 30-34, Female, Positive 2019 469
TX_NEW 30-34, Female, Positive 2019 68
TX_NEW 30-34, Male, Positive 2019 474
TX_NEW 30-34, Male, Positive 2019 68
TX_NEW 35-39, Female, Positive 2019 489
TX_NEW 35-39, Female, Positive 2019 70
TX_NEW 35-39, Male, Positive 2019 642
TX_NEW 35-39, Male, Positive 2019 92
TX_NEW 40-49, Female, Positive 2019 331
TX_NEW 40-49, Female, Positive 2019 48
TX_NEW 40-49, Male, Positive 2019 598
TX_NEW 40-49, Male, Positive 2019 85
TX_NEW Breastfeeding status 2019 699
TX_NEW Breastfeeding status 2019 99
TX_NEW By Age/Sex: <1 2019 113
TX_NEW By Age/Sex: <1 2019 3
TX_NEW By Age/Sex: 1-9 2019 666
TX_NEW By Age/Sex: 1-9 2019 36
TX_NEW By Age/Sex: 10-14 Female 2019 617
TX_NEW By Age/Sex: 10-14 Female 2019 33
TX_NEW By Age/Sex: 10-14 Male 2019 153
TX_NEW By Age/Sex: 10-14 Male 2019 7
TX_NEW By Age/Sex: 15-19 Female 2019 467
TX_NEW By Age/Sex: 15-19 Female 2019 68
TX_NEW By Age/Sex: 15-19 Male 2019 153
TX_NEW By Age/Sex: 15-19 Male 2019 20
TX_NEW By Age/Sex: 20-24 Female 2019 866
TX_NEW By Age/Sex: 20-24 Female 2019 125
TX_NEW By Age/Sex: 20-24 Male 2019 386
TX_NEW By Age/Sex: 20-24 Male 2019 56
TX_NEW By Age/Sex: 50+ Female 2019 18
TX_NEW By Age/Sex: 50+ Female 2019 2
TX_NEW By Age/Sex: 50+ Male 2019 289
TX_NEW By Age/Sex: 50+ Male 2019 38
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 8,536
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 1,082
TX_NEW Pregnancy status 2019 699
TX_NEW Pregnancy status 2019 99
TX_NEW Sum of Age/Sex disaggregates 2019 2,949
TX_NEW Sum of Age/Sex disaggregates 2019 349
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 74,863
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 11,790
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 2,996
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 472
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 411
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 67
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 1,498
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 236
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 207
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 28
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 41,173
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 6,483
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 6,199
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 982
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 19,464
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 3,066
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 2,915
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 456
TX_PVLS_den Denominator: Indication: Routine 2019 65,131
TX_PVLS_den Denominator: Indication: Routine 2019 10,257
TX_PVLS_den Denominator: Indication: Targeted 2019 9,732
TX_PVLS_den Denominator: Indication: Targeted 2019 1,533
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 589
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 40
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 320
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 19
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 12,162
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,050
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 10,790
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 926
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 23,861
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 2,035
TX_RET Numerator by Status: Breastfeeding 2019 2,298
TX_RET Numerator by Status: Breastfeeding 2019 195
TX_RET Numerator by Status: Pregnant 2019 2,298
TX_RET Numerator by Status: Pregnant 2019 195
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 26,512
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 2,261
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 656
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 44
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 353
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 23
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 13,513
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,165
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 11,990
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,029
TX_RET_den Denominator by Status: Breastfeeding 2019 2,550
TX_RET_den Denominator by Status: Breastfeeding 2019 222
TX_RET_den Denominator by Status: Pregnant 2019 2,550
TX_RET_den Denominator by Status: Pregnant 2019 222
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 83,175
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 13,105
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 4,991
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 786
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 3,329
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 523
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 7,998
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 3,798
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 50,732
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 24,123
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 2,491
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 397
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 172
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 22
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 666
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 104
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 523
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 3,329
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 72,359
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 11,403
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 2,164
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 340
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 8,318
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 1,310
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 334
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 52
VMMC_CIRC 30-34, Male 2019 2,252
VMMC_CIRC 35-39, Male 2019 2,252
VMMC_CIRC 40-49, Male 2019 2,252
VMMC_CIRC By Age: 10-14 2019 2,816
VMMC_CIRC By Age: 15-19 2019 14,079
VMMC_CIRC By Age: 20-24 2019 14,079
VMMC_CIRC By Age: 25-29 2019 16,893
VMMC_CIRC By Age: 50+ 2019 1,676
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 56,299
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 56,299
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 49,543
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 32,650
Cross Cutting Budget Categories and Known Amounts Total: $1,704,084
Key Populations: MSM and TG $118,165
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $177,246
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Gender: Gender Based Violence (GBV) $252,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $212,509
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Capacity building
Implementation
Collection and Use of Gender-related Strategic Information
Increase gender-equitable access to income and productive resources, including education
Monitoring and Evaluation
Capacity building
Implementation
Collection and Use of Gender-related Strategic Information
Food and Nutrition: Policy, Tools, and Service Delivery $354,499
Condoms: Policy, Tools, and Services $472,665
Water $117,000